Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 26% ± 7% | |
fibroblast | 9 studies | 23% ± 8% | |
oligodendrocyte | 8 studies | 27% ± 8% | |
glutamatergic neuron | 7 studies | 38% ± 23% | |
astrocyte | 7 studies | 25% ± 9% | |
natural killer cell | 6 studies | 19% ± 2% | |
type I pneumocyte | 6 studies | 21% ± 4% | |
basal cell | 6 studies | 28% ± 12% | |
epithelial cell | 6 studies | 38% ± 14% | |
ciliated cell | 6 studies | 27% ± 11% | |
GABAergic neuron | 6 studies | 35% ± 16% | |
macrophage | 5 studies | 23% ± 4% | |
oligodendrocyte precursor cell | 5 studies | 28% ± 9% | |
interneuron | 5 studies | 34% ± 20% | |
plasmacytoid dendritic cell | 5 studies | 21% ± 4% | |
pancreatic A cell | 4 studies | 29% ± 9% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 2% | |
CD8-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
neuron | 4 studies | 32% ± 7% | |
retinal bipolar neuron | 4 studies | 25% ± 7% | |
microglial cell | 4 studies | 21% ± 3% | |
myofibroblast cell | 4 studies | 19% ± 1% | |
pericyte | 4 studies | 19% ± 2% | |
retina horizontal cell | 4 studies | 23% ± 7% | |
adipocyte | 4 studies | 20% ± 4% | |
secretory cell | 3 studies | 29% ± 14% | |
type B pancreatic cell | 3 studies | 37% ± 9% | |
B cell | 3 studies | 19% ± 1% | |
CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
classical monocyte | 3 studies | 27% ± 7% | |
conventional dendritic cell | 3 studies | 31% ± 12% | |
non-classical monocyte | 3 studies | 28% ± 6% | |
plasmablast | 3 studies | 32% ± 13% | |
club cell | 3 studies | 24% ± 3% | |
amacrine cell | 3 studies | 30% ± 8% | |
retinal cone cell | 3 studies | 25% ± 7% | |
retinal rod cell | 3 studies | 19% ± 0% | |
rod bipolar cell | 3 studies | 24% ± 1% | |
respiratory goblet cell | 3 studies | 24% ± 9% | |
abnormal cell | 3 studies | 24% ± 3% | |
endothelial cell of lymphatic vessel | 3 studies | 19% ± 4% | |
goblet cell | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2563.20 | 1445 / 1445 | 100% | 28.24 | 183 / 183 |
breast | 100% | 2587.43 | 459 / 459 | 100% | 46.36 | 1117 / 1118 |
lung | 100% | 2500.01 | 578 / 578 | 100% | 26.14 | 1153 / 1155 |
prostate | 100% | 2566.94 | 245 / 245 | 100% | 34.06 | 501 / 502 |
bladder | 100% | 2855.67 | 21 / 21 | 99% | 24.59 | 501 / 504 |
uterus | 100% | 2770.85 | 170 / 170 | 99% | 25.17 | 456 / 459 |
thymus | 100% | 3020.22 | 653 / 653 | 99% | 30.23 | 601 / 605 |
intestine | 100% | 2499.43 | 966 / 966 | 99% | 21.61 | 523 / 527 |
pancreas | 100% | 1387.95 | 327 / 328 | 99% | 24.05 | 177 / 178 |
liver | 100% | 1410.22 | 226 / 226 | 99% | 19.17 | 402 / 406 |
brain | 99% | 1616.06 | 2614 / 2642 | 100% | 25.18 | 705 / 705 |
adrenal gland | 100% | 2471.40 | 258 / 258 | 99% | 24.38 | 227 / 230 |
kidney | 100% | 2006.22 | 89 / 89 | 99% | 23.64 | 888 / 901 |
stomach | 100% | 2026.73 | 359 / 359 | 98% | 22.46 | 281 / 286 |
ovary | 100% | 2187.39 | 180 / 180 | 98% | 14.47 | 422 / 430 |
skin | 100% | 3346.91 | 1809 / 1809 | 96% | 26.74 | 453 / 472 |
adipose | 100% | 2568.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2909.52 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.54 | 29 / 29 |
muscle | 100% | 3209.95 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1800.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.40 | 1 / 1 |
heart | 96% | 1659.33 | 823 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 13.37 | 66 / 80 |
peripheral blood | 71% | 859.83 | 657 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001731 | Biological process | formation of translation preinitiation complex |
GO_0045948 | Biological process | positive regulation of translational initiation |
GO_0042255 | Biological process | ribosome assembly |
GO_0005622 | Cellular component | intracellular anatomical structure |
GO_0016282 | Cellular component | eukaryotic 43S preinitiation complex |
GO_0022627 | Cellular component | cytosolic small ribosomal subunit |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0004386 | Molecular function | helicase activity |
GO_0043024 | Molecular function | ribosomal small subunit binding |
GO_0008494 | Molecular function | translation activator activity |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0017111 | Molecular function | ribonucleoside triphosphate phosphatase activity |
Gene name | DHX29 |
Protein name | DExH-box helicase 29 ATP-dependent RNA helicase DHX29 (EC 3.6.4.13) (DEAH box protein 29) (Nucleic acid helicase DDXx) |
Synonyms | DDX29 |
Description | FUNCTION: ATP-binding RNA helicase involved in translation initiation. Part of the 43S pre-initiation complex that is required for efficient initiation on mRNAs of higher eukaryotes with structured 5'-UTRs by promoting efficient NTPase-dependent 48S complex formation. Specifically binds to the 40S ribosome near the mRNA entrance. Does not possess a processive helicase activity. . |
Accessions | H0Y8L1 Q7Z478 ENST00000508346.1 ENST00000251636.10 |